EQUILLIUM, INC. Operating Lease, Expense
EQUILLIUM, INC. (EQ) reported Operating Lease, Expense of $100.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-11-13
- EQUILLIUM, INC. operating lease, expense for the quarter ending 2024-09-30 was $100.00K, a 0.00% change year-over-year.
- EQUILLIUM, INC. operating lease, expense for the quarter ending 2024-06-30 was $100.00K, a 0.00% change year-over-year.
- EQUILLIUM, INC. operating lease, expense for the quarter ending 2024-03-31 was $100.00K, a 0.00% change year-over-year.
- EQUILLIUM, INC. operating lease, expense for the quarter ending 2023-12-31 was $100.00K, a 50.00% decline year-over-year.
- EQUILLIUM, INC. operating lease, expense for fiscal 2023 was $500.00K, a 16.67% decline from fiscal 2022.
- EQUILLIUM, INC. operating lease, expense for fiscal 2022 was $600.00K, a 100.00% increase from fiscal 2021.
- EQUILLIUM, INC. operating lease, expense for fiscal 2021 was $300.00K, a 50.00% increase from fiscal 2020.
- EQUILLIUM, INC. operating lease, expense for fiscal 2020 was $200.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-13 | $200.00K derived: sum of 2 quarters · filed 2024-11-13 | $400.00K 10-Q · filed 2024-11-13 | $400.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-08 | $300.00K 10-Q · filed 2024-08-08 | $300.00K derived: sum of 3 quarters · filed 2024-08-08 | $400.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-09 | $200.00K derived: sum of 2 quarters · filed 2024-05-09 | $300.00K derived: sum of 3 quarters · filed 2024-11-13 | $400.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $200.00K derived: sum of 2 quarters · filed 2024-11-13 | $300.00K derived: sum of 3 quarters · filed 2024-11-13 | $500.00K 10-K · filed 2024-03-25 |
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-13 | $200.00K derived: sum of 2 quarters · filed 2024-11-13 | $400.00K 10-Q · filed 2024-11-13 | $500.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-08 | $300.00K 10-Q · filed 2024-08-08 | $400.00K derived: sum of 3 quarters · filed 2024-08-08 | $500.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-09 | $300.00K derived: sum of 2 quarters · filed 2024-05-09 | $400.00K derived: sum of 3 quarters · filed 2024-05-09 | $600.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $300.00K derived: sum of 2 quarters · filed 2024-03-25 | $500.00K derived: sum of 3 quarters · filed 2024-03-25 | $600.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-08 | $300.00K derived: sum of 2 quarters · filed 2023-11-08 | $400.00K 10-Q · filed 2023-11-08 | $400.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $200.00K 10-Q · filed 2023-08-09 | $300.00K 10-Q · filed 2023-08-09 | $300.00K derived: sum of 3 quarters · filed 2023-08-09 | $400.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-11 | $100.00K derived: sum of 2 quarters · filed 2023-05-11 | $200.00K derived: sum of 3 quarters · filed 2023-05-11 | $300.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $100.00K derived: sum of 2 quarters · filed 2023-03-23 | $200.00K derived: sum of 3 quarters · filed 2023-03-23 | $300.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-14 | $200.00K derived: sum of 2 quarters · filed 2022-11-14 | $300.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-15 | $100.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $200.00K 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |